DOXY

This brand name is authorized in France, Hong Kong, Israel, New Zealand, United States

Active ingredients

The drug DOXY contains one active pharmaceutical ingredient (API):

1 Doxycycline UNII 19XTS3T51U - DOXYCYCLINE HYCLATE

Doxycycline is primarily bacteriostatic and is believed to exert its antimicrobial effect by the inhibition of protein synthesis. Read about Doxycycline

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DOXY Powder for solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01AA02	Doxycycline	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01A Tetracyclines → J01AA Tetracyclines
Discover more medicines within J01AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 61722191, 67061569
Country: HK	Department of Health Drug Office	Identifier(s): 38107, 42036
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3532
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 2731, 2733
Country: US	FDA, National Drug Code	Identifier(s): 51662-1402, 52584-028, 63323-130